Form 4 for KYTX Kyverna Therapeutics, Inc.
Accepted 2025-12-17 00:00:00 ET · period of report 2025-12-15 · accession 0001193125-25-323332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-12-17 | 2025-12-15 | KYTX | Walker Karen Marie | CTO | M - OptEx | $4.83 | +24.0K | 46.6K | +106% | +$115.9K |
| DT | 2025-12-17 | 2025-12-15 | KYTX | Walker Karen Marie | CTO | S - Sale+OE | $12.20 | -24.0K | 22.6K | -51% | -$292.8K |
| DT | 2025-12-17 | 2025-12-15 | KYTX | Walker Karen Marie | CTO | M - OptEx | $0.00 | -24.0K | 85.9K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-15 | M | A | 23,998 | $4.83 | 46,634 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-15 | S | D | 23,998 | $12.20 | 22,636 | D | — | — | |
| 3 | Derivative | Stock option (right to buy) | 2025-12-15 | M | D | 23,998 | $0.00 | 85,865 | D | $4.83 · — to 2033-11-05 | 23,998 Common Stock | (F2) 25% of the original number of shares subject to the option vested on January 1, 2025, and 1/48th of the original number of shares subject to the option vests in monthly installments thereafter, subject to the Reporting Person's continuous service. |